Abstract
Purpose
Large-scale waterborne epidemics of hepatitis E occur in developing countries. It is not known why these epidemics occur repeatedly and selectively in adult population?
Methods
We studied seroepidemiology of an outbreak of hepatitis E in one of 15 villages that had recorded first epidemic of hepatitis E 30 years back. Another village not affected by the second epidemic was taken as a control. Overall, 1,216 sera were collected (638 from the epidemic village and 578 from the control village) for serological markers of both hepatitis A virus (HAV) and hepatitis E virus (HEV).
Results
The seroprevalence of anti-HEV in this population following the first epidemic in 1978 was 29.4%. Antibodies were detected in only 47% of the 45 patients affected by icteric HEV infection 14 years after the first epidemic. At 30-year follow-up, the seroprevalence of anti-HEV was only 4.5% (26/578). In the village affected by second epidemic, 138 (21.6%) subjects had serological evidence of recent HEV infection. The attack rate was 23.6% (78/330) in children (≤14 years) and 19.4% (60/308) in adults (P = 0.21). The attack rate of anicteric HEV infection was 21.8% (72/330) in children and 14.6% (45/308) in adults (P = 0.02).
Conclusions
Following hepatitis E epidemics, there is a gradual loss of antibodies in the community over the decades and poor exposure to HEV infection in the cohort of population born during the interepidemic period. The next epidemic occurs when antibody levels fall to critically low levels and there is associated gross fecal contamination of water resources. During epidemic, persons of all age groups are exposed to infection, with predominant anicteric disease in children.
Similar content being viewed by others
References
Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818–824
Wong DC, Purcell RH, Sreenivason MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus etiology. Lancet 1980;2:882–885
Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983;20(1):23–31
Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247(4948):1335–1339
Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008;80(4):646–658
Panda SK, Thakral D, Rehman S. Hepatitis E virus. Rev Med Virol 2007;17:151–180
Khuroo MS, Khuroo MS. Hepatitis E virus. Curr Opin Infect Dis 2008;21:539–543
Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252–255
Khuroo MS, Kamili S. Etiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003;10:61–69
Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147(1):28–33
Khuroo MS, Kamili S. Association of severity of hepatitis E virus infection in the mother and vertically transmitted infection in the fetus. JK Pract 2006;13:70–74
Khuroo MS, Khuroo N. Hepatitis E: global epidemiology with special reference to impact of the disease in India and the Southeast of Asia. In Rizzetto M, Purcell RH, Gerin JL, Vernie G, editors. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica; 1997. 601–608
Skidmore SJ, Yarbough PO, Gabor KA, Reyes GR. Hepatitis E virus: the cause of a waterborne hepatitis outbreak. J Med Virol 1992;37:58–60
Kamili S, Khuroo MS, Jameel S. Hepatitis E: Studies on Transmission, Etiological Agent and Sero-epidemiology. PhD thesis. Srinagar: University of Kashmir; 1994
Khuroo MS, Saleem M, Teli MR, Sofi MA. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis (letter). Lancet 1980;2:97–98
Khuroo MS, Jameel S, Kamili S, Moecklii R, Dar MY. Hepatitis E and long term antibody status (letter). Lancet 1993;341:1355
Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E virus in rural Egyptian communities. Am J Trop Med Hyg 2000;62:519–523
Arankalle VA, Tsarev SA, Chada MS, et al. Age specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447–450
Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895–903
Krawczynski K. Hepatitis E vaccine-ready for prime time? N Engl J Med 2007;356:949–951
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s12072-010-9182-6
Rights and permissions
About this article
Cite this article
Khuroo, M.S., Khuroo, M.S. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol Int 4, 494–499 (2010). https://doi.org/10.1007/s12072-009-9159-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-009-9159-5